Intrarectal lidocaine is an effective treatment for abdominal pain associated with diarrhea-predominant irritable bowel syndrome

Journal of Pain

Volumn 6, Issue 8, 2005, Pages 493-496

  Verne, G Nicholas ^a   Sen, Arup ^a   Price, Donald D ^a,b  

^a LLC   (United States)

^b NONE   (United States)

Author keywords

Abdominal pain; Irritable bowel syndrome; Lidocaine; Visceral hypersensitivity

Indexed keywords

FLEET ENEMA; LIDOCAINE; PLACEBO; SODIUM CHANNEL; SODIUM CHLORIDE;

ABDOMINAL PAIN; ADULT; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CLINICAL TRIAL; COLON; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERSENSITIVITY; INTERMETHOD COMPARISON; IRRITABLE COLON; ITALY; PAIN ASSESSMENT; PARESTHESIA; PREMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SENSORY NERVE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ABDOMINAL PAIN; ADMINISTRATION, RECTAL; ADULT; ANESTHETICS, LOCAL; COLON; CROSS-OVER STUDIES; DIARRHEA; DOUBLE-BLIND METHOD; ENTERIC NERVOUS SYSTEM; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; LIDOCAINE; NEURONS, AFFERENT; PROSPECTIVE STUDIES; SODIUM CHANNELS; SUPPOSITORIES; TREATMENT OUTCOME; VISCERAL AFFERENTS;

EID: 23444433183     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2005.02.009     Document Type: Article

References (12)

1. D.E. Baker Tegaserod for the treatment of constipation-predominant irritable bowel syndrome Rev Gastroenterol Disord 1 2001 187 198
2. A.G. de Boer, D.D. Breimer, H. Mattie, J. Pronk, J.M. Gubbens-Stibbe Rectal bioavailability of lidocaine in man: partial avoidance of "first- pass" metabolism Clin Pharmacol Ther 26 1979 701 709
3. R.C. Dunphy, L. Bridgewater, D.D. Price, M.E. Robinson, C.J. Zeilman, G.N. Verne Visceral and cutaneous hypersensitivity in Persian Gulf war veterans with chronic gastrointestinal symptoms Pain 102 2003 79 85
4. J.T. Farrar, R.K. Portenoy, J.A. Berlin, J.L. Kinman, B.L. Strom Defining the clinically important difference in pain outcome measures Pain 88 2000 287 294
5. A. Lembo, H.C. Weber, F.A. Farraye Alosetron in irritable bowel syndrome: strategies for its use in a common gastrointestinal disorder Drugs 63 2003 1895 1905
6. T. Lembo, J. Munakata, H. Mertz, N. Niazi, A. Kodner, V. Nikas, E.A. Mayer Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome Gastroenterology 107 1994 1686 1696
7. H. Mertz, B. Naliboff, J. Munakata, N. Niazi, E.A. Mayer Altered rectal perception is a biological marker of patients with irritable bowel syndrome Gastroenterology 109 1995 40 52
8. B.D. Naliboff, J. Munakata, S. Fullerton, R.H. Gracely, A. Kodner, F. Harraf, E.A. Mayer Evidence for two distinct perceptual alterations in irritable bowel syndrome Gut 41 1997 505 512
9. D.D. Price, F.M. Bush, S. Long, S.W. Harkins A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales Pain 56 1994 217 226
10. W.G. Thompson, G.F. Longstreth, D.A. Drossman, K.W. Heaton, E.J. Irvine, S.A. Muller-Lissner Functional bowel disorders and functional abdominal pain Gut 45 Suppl 2 1999 II43 II47
11. G.N. Verne, M.E. Robinson, D.D. Price Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome Pain 93 2001 7 14
12. G.N. Verne, M.E. Robinson, L. Vase, D.D. Price Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients Pain 105 2003 223 230